UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Transcriptome-wide profiles of circular RNA and RNA-binding protein interactions reveal effects on circular RNA biogenesis and cancer pathway expression

Genome medicine, 2020-12, Vol.12 (1), p.112-22, Article 112

2020

Link zum Volltext

Verfügbarkeit prüfen

Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20), p.5758-5771

2014

Link zum Volltext

Verfügbarkeit prüfen

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial

BMC cancer, 2024-02, Vol.24 (1), p.260-260, Article 260

2024

Link zum Volltext

Verfügbarkeit prüfen

Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer

Cell reports (Cambridge), 2014-06, Vol.7 (5), p.1649-1663

2014

Link zum Volltext

Verfügbarkeit prüfen

Cytoreductive Nephrectomy in Select Primary Metastatic Renal Cell Carcinoma Patients: A Comprehensive Nationwide Outcome Analysis

Cancers, 2024-03, Vol.16 (6), p.1132

2024

Link zum Volltext

Verfügbarkeit prüfen

Lifestyle and Clinical Factors in a Nationwide Stage III and IV Renal Cell Carcinoma Study

Cancers, 2023-09, Vol.15 (18), p.4488

2023

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer

The American journal of pathology, 2013-02, Vol.182 (2), p.339-349

2013

Link zum Volltext

Verfügbarkeit prüfen

First-line therapy in patients with metastatic renal cell carcinoma (mRCC): Results from consecutive patients over 25 years in a single institution

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16574-e16574

2021

Link zum Volltext

Verfügbarkeit prüfen

Folic Acid Reduces Mucositis in Metastatic Renal Cell Carcinoma Patients: A Retrospective Study

Clinical genitourinary cancer, 2019-08, Vol.17 (4), p.254-259

2019

Link zum Volltext

Verfügbarkeit prüfen

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression

BMC cancer, 2009-10, Vol.9 (1), p.385-385, Article 385

2009

Link zum Volltext

Verfügbarkeit prüfen

Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic

Clinical cancer research, 2024-02, Vol.30 (4), p.663

2024

Link zum Volltext

Verfügbarkeit prüfen

KIDNEY-PAGER: analysis of circulating tumor DNA as a biomarker in renal cancer - an observational trial. Study protocol

Acta oncologica, 2024-02, Vol.63, p.51-55

2024

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Drug Monitoring for Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma

Clinical genitourinary cancer, 2024-06, Vol.22 (3), p.102064-102064, Article 102064

2024

Link zum Volltext

Verfügbarkeit prüfen

Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 is Associated with Poor Outcome and Promotes Cell Death In vitro

Cancer research (Chicago, Ill.), 2009-06, Vol.69 (11), p.4851-4860

2009

Link zum Volltext

Verfügbarkeit prüfen

Dealing with pre-existing chronic neutropenia in cancer patients— considerations and consequences in the clinical praxis

Ecancermedicalscience, 2020-10, Vol.14

2020

Link zum Volltext

Verfügbarkeit prüfen

Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer

BJU international, 2012-12, Vol.110 (11c), p.E1228-E1236

2012

Link zum Volltext

Verfügbarkeit prüfen

Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer

The American journal of pathology, 2012-05, Vol.180 (5), p.1824-1834

2012

Link zum Volltext

Verfügbarkeit prüfen

High Expression of Karyopherin-α2 Defines Poor Prognosis in Non–Muscle-Invasive Bladder Cancer and in Patients with Invasive Bladder Cancer Undergoing Radical Cystectomy

European urology, 2011-05, Vol.59 (5), p.841-848

2011

Link zum Volltext

Verfügbarkeit prüfen

Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort

BJUI compass, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3153: Whole genome and transcriptome analysis reveals novel genomic alterations in bladder cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3153-3153

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3109: Correlation between genomic aberrations and the DNA damage response in bladder cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3109-3109

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4642: Risk stratification of bladder cancer patients using a panel of 5 prognostic protein markers

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4642-4642

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3657: MCM7, ADAM10, TRIM29, Aurora Kinase B, and Cyclin D1: A panel of prognostic protein markers for progression in non-muscle invasive bladder cancer - a multicenter tissue microarray validation study

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3657-3657

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3656: Cathepsin E, Maspin, PLK1, and Survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3656-3656

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4182: Tissue microarray validation of Cathepsin E, Maspin, PLK-1, Survivin and TRIM29 expression as prognostic protein markers for stage pTa and pT1 urothelial carcinoma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4182-4182

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(22)
Humans
(17)
Oncology
(11)
Female
(9)
Male
(9)
Aged
(7)
Middle Aged
(7)
Adult
(6)
Aged, 80 And Over
(6)
Urinary Bladder Neoplasms - Genetics
(6)
Urinary Bladder Neoplasms - Pathology
(6)
Gene Expression Regulation, Neoplastic
(5)
Neoplasm Invasiveness
(5)
Urinary Bladder Neoplasms - Metabolism
(5)
Bladder Cancer
(4)
Cancer
(4)
Denmark
(4)
Kidney Cancer
(4)
Patients
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Transcriptome-wide profiles of circular RNA and RNA-binding protein interactions reveal effects on circular RNA biogenesis and cancer pathway expression

Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial

Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer

Cytoreductive Nephrectomy in Select Primary Metastatic Renal Cell Carcinoma Patients: A Comprehensive Nationwide Outcome Analysis

Lifestyle and Clinical Factors in a Nationwide Stage III and IV Renal Cell Carcinoma Study

Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer

First-line therapy in patients with metastatic renal cell carcinoma (mRCC): Results from consecutive patients over 25 years in a single institution

Folic Acid Reduces Mucositis in Metastatic Renal Cell Carcinoma Patients: A Retrospective Study

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression

Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic

KIDNEY-PAGER: analysis of circulating tumor DNA as a biomarker in renal cancer - an observational trial. Study protocol

Therapeutic Drug Monitoring for Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma

Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 is Associated with Poor Outcome and Promotes Cell Death In vitro

Dealing with pre-existing chronic neutropenia in cancer patients— considerations and consequences in the clinical praxis

Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer

Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer

High Expression of Karyopherin-α2 Defines Poor Prognosis in Non–Muscle-Invasive Bladder Cancer and in Patients with Invasive Bladder Cancer Undergoing Radical Cystectomy

Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort

Abstract 3153: Whole genome and transcriptome analysis reveals novel genomic alterations in bladder cancer

Abstract 3109: Correlation between genomic aberrations and the DNA damage response in bladder cancer

Abstract 4642: Risk stratification of bladder cancer patients using a panel of 5 prognostic protein markers

Abstract 3657: MCM7, ADAM10, TRIM29, Aurora Kinase B, and Cyclin D1: A panel of prognostic protein markers for progression in non-muscle invasive bladder cancer - a multicenter tissue microarray validation study

Abstract 3656: Cathepsin E, Maspin, PLK1, and Survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer

Abstract 4182: Tissue microarray validation of Cathepsin E, Maspin, PLK-1, Survivin and TRIM29 expression as prognostic protein markers for stage pTa and pT1 urothelial carcinoma

Suchergebnisse filtern